HMG-CoA还原酶抑制剂（氟伐他汀和洛伐他汀）引起的苔藓样药疹。 - Suppr

Suppr

超能文献

Lichenoid drug eruption with HMG-CoA reductase inhibitors (fluvastatin and lovastatin).

作者信息

Sebök Bela, Tóth Margit, Anga Bela, Harangi Ferenc, Schneider Imre

出版信息

Acta Derm Venereol. 2004;84(3):229-30. doi: 10.1080/00015550310006851.

DOI:10.1080/00015550310006851

PMID:15202842

Abstract

摘要

相似文献

Lichenoid drug eruption with HMG-CoA reductase inhibitors (fluvastatin and lovastatin).

Acta Derm Venereol. 2004;84(3):229-30. doi: 10.1080/00015550310006851.

Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia.

Ann Pharmacother. 1995 Jul-Aug;29(7-8):743-59. doi: 10.1177/106002809502907-818.

Meeting national cholesterol education goals in clinical practice--a comparison of lovastatin and fluvastatin in primary prevention.

Am J Cardiol. 1996 Sep 26;78(6A):26-31. doi: 10.1016/s0002-9149(96)00659-5.

Fluvastatin and cancer.

Int J Clin Pract. 2007 Jan;61(1):168; author reply 168-9. doi: 10.1111/j.1742-1241.2006.01205.x.

Development of tachyphylaxis among patients taking HMG CoA reductase inhibitors.

Am J Cardiol. 2000 Nov 15;86(10):1123-7. doi: 10.1016/s0002-9149(00)01171-1.

[High therapeutic effect and safety of fluvastatin].

Pharm Unserer Zeit. 2003;32(6):516-7. doi: 10.1002/pauz.200390134.

Is decreased libido associated with the use of HMG-CoA-reductase inhibitors?

Br J Clin Pharmacol. 2004 Sep;58(3):326-8. doi: 10.1111/j.1365-2125.2004.02128.x.

Two different types of exercise-induced muscle pain without myopathy and CK-elevation during HMG-Co-enzyme-A-reductase inhibitor treatment.

Atherosclerosis. 1999 Apr;143(2):459-60. doi: 10.1016/s0021-9150(98)00310-4.

Benefits and risks of HMG-CoA reductase inhibitors in the prevention of coronary heart disease: a reappraisal.

Drug Saf. 1996 Jan;14(1):11-24. doi: 10.2165/00002018-199614010-00003.

Fluvastatin, rhabdomyolysis, and myotoxicity.

Mayo Clin Proc. 2008 Nov;83(11):1296; author reply 1297. doi: 10.4065/83.11.1296.

引用本文的文献

Rosuvastatin-Induced Oral Ulcer: A Case Report and Review of Literature.

Case Rep Dent. 2022 Mar 29;2022:7960513. doi: 10.1155/2022/7960513. eCollection 2022.

Atorvastatin-induced Lichenoid Drug Eruption: A Case Report and Review of Statin-associated Cutaneous Adverse Events.

Cureus. 2020 Mar 1;12(3):e7155. doi: 10.7759/cureus.7155.

Folate and Vitamin B12 Levels in Thai Patients with Oral Lichenoid Related Drug.

Acta Stomatol Croat. 2015 Sep;49(3):214-20. doi: 10.15644/asc49/3/3.

Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Am J Cardiovasc Drugs. 2008;8(6):373-418. doi: 10.2165/0129784-200808060-00004.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Lichenoid drug eruption with HMG-CoA reductase inhibitors (fluvastatin and lovastatin).

作者信息

Sebök Bela, Tóth Margit, Anga Bela, Harangi Ferenc, Schneider Imre

出版信息

Acta Derm Venereol. 2004;84(3):229-30. doi: 10.1080/00015550310006851.

DOI:10.1080/00015550310006851

PMID:15202842

Abstract

摘要

相似文献

Lichenoid drug eruption with HMG-CoA reductase inhibitors (fluvastatin and lovastatin).

Acta Derm Venereol. 2004;84(3):229-30. doi: 10.1080/00015550310006851.

Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia.

Ann Pharmacother. 1995 Jul-Aug;29(7-8):743-59. doi: 10.1177/106002809502907-818.

Meeting national cholesterol education goals in clinical practice--a comparison of lovastatin and fluvastatin in primary prevention.

Am J Cardiol. 1996 Sep 26;78(6A):26-31. doi: 10.1016/s0002-9149(96)00659-5.

Fluvastatin and cancer.

Int J Clin Pract. 2007 Jan;61(1):168; author reply 168-9. doi: 10.1111/j.1742-1241.2006.01205.x.

Development of tachyphylaxis among patients taking HMG CoA reductase inhibitors.

Am J Cardiol. 2000 Nov 15;86(10):1123-7. doi: 10.1016/s0002-9149(00)01171-1.

[High therapeutic effect and safety of fluvastatin].

Pharm Unserer Zeit. 2003;32(6):516-7. doi: 10.1002/pauz.200390134.

Is decreased libido associated with the use of HMG-CoA-reductase inhibitors?

Br J Clin Pharmacol. 2004 Sep;58(3):326-8. doi: 10.1111/j.1365-2125.2004.02128.x.

Two different types of exercise-induced muscle pain without myopathy and CK-elevation during HMG-Co-enzyme-A-reductase inhibitor treatment.

Atherosclerosis. 1999 Apr;143(2):459-60. doi: 10.1016/s0021-9150(98)00310-4.

Benefits and risks of HMG-CoA reductase inhibitors in the prevention of coronary heart disease: a reappraisal.

Drug Saf. 1996 Jan;14(1):11-24. doi: 10.2165/00002018-199614010-00003.

Fluvastatin, rhabdomyolysis, and myotoxicity.

Mayo Clin Proc. 2008 Nov;83(11):1296; author reply 1297. doi: 10.4065/83.11.1296.

引用本文的文献

Rosuvastatin-Induced Oral Ulcer: A Case Report and Review of Literature.

Case Rep Dent. 2022 Mar 29;2022:7960513. doi: 10.1155/2022/7960513. eCollection 2022.

Atorvastatin-induced Lichenoid Drug Eruption: A Case Report and Review of Statin-associated Cutaneous Adverse Events.

Cureus. 2020 Mar 1;12(3):e7155. doi: 10.7759/cureus.7155.

Folate and Vitamin B12 Levels in Thai Patients with Oral Lichenoid Related Drug.

Acta Stomatol Croat. 2015 Sep;49(3):214-20. doi: 10.15644/asc49/3/3.

Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Am J Cardiovasc Drugs. 2008;8(6):373-418. doi: 10.2165/0129784-200808060-00004.